Modifying a child’s immune system to fight off leukemia can yield dramatic results, but the treatments are dangerous and no one knows if they’re permanent.
Cattle that can crank out human antibodies are being tested as a first line of defense against infectious diseases.
There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.
Nobody agrees on how best to collect data about diseases that threaten human health. That looks set to change.
Fertility doctors used a controversial technique to create a single egg from two women’s DNA, fertilized it, and watched as it grew into a healthy baby.
The approach could be a tenth the price of earlier methods.
The medical maker collective Four Thieves Vinegar made an “EpiPencil” for a tiny fraction of what the EpiPen manufacturer Mylan charges.
For patients with some inherited diseases, a chance to test an experimental treatment can offer the only hope.
Mapping the 3-D network structure of a fly’s brain is a major step forward. But it took 1,700 person-hours to complete, meaning that human labor will be a significant bottleneck for future advances.
Can cell therapy help spinal-cord injury? A long-running study hopes the answer is yes.